Compare GKOS & SR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GKOS | SR |
|---|---|---|
| Founded | 1998 | 1857 |
| Country | United States | United States |
| Employees | N/A | 3497 |
| Industry | Medical/Dental Instruments | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.0B | 5.4B |
| IPO Year | 2015 | N/A |
| Metric | GKOS | SR |
|---|---|---|
| Price | $141.22 | $90.50 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 9 |
| Target Price | ★ $126.92 | $91.33 |
| AVG Volume (30 Days) | ★ 642.1K | 265.1K |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.68% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $507,442,000.00 | N/A |
| Revenue This Year | $23.32 | $6.81 |
| Revenue Next Year | $27.43 | $2.31 |
| P/E Ratio | ★ N/A | $19.47 |
| Revenue Growth | ★ 32.33 | N/A |
| 52 Week Low | $73.16 | $71.24 |
| 52 Week High | $145.50 | $95.31 |
| Indicator | GKOS | SR |
|---|---|---|
| Relative Strength Index (RSI) | 73.45 | 47.68 |
| Support Level | $80.14 | $88.77 |
| Resistance Level | N/A | $92.20 |
| Average True Range (ATR) | 4.95 | 1.80 |
| MACD | 1.69 | -0.20 |
| Stochastic Oscillator | 86.28 | 42.75 |
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.
Spire Inc. is the holding company for Spire Missouri, Spire Alabama, other gas utilities, and gas-related businesses, focused on growing organically, investing in infrastructure, and advancing through innovation. Its three segments are Gas Utility, Gas Marketing, and Midstream. The Gas Utility segment is the core business and includes Spire Missouri, Spire Alabama, and Spire EnergySouth. The Gas Marketing segment includes Spire Marketing, which provides non-regulated natural gas services across the U.S. The Midstream segment includes Spire Storage, Spire STL Pipeline, and Spire MoGas Pipeline. The majority of revenue comes from Gas Utility.